Led by the Chief Executive Officer of MHRA Prof Kent Woods and Dr Gerald Heddell, the head of Inspection and Vigilance, a senior delegation of UK regulators will be holding a series of seminars across four cities in India from December 3-10.
The UK MHRA team is slated to engage in day long workshops/seminars with regulators at the state and central level in Mumbai (on December 3), Ahmedabad (December 5) and Hyderabad (December 7).
In Delhi, the team is scheduled to have a closed door meeting with the Drug Controller General (India).
The UK MHRA team is being supported by Pharmexcil and the UK Trade & Investment (UKTI) on this initiative. The day long workshops will serve to acquaint both the UK and Indian regulators with the responsibilities and procedures of the regulatory counterparts. UKTI representatives will also outline investment opportunities in the UK.
EP News Bureau